Login

Healthcare

00:10:00
Novel Cell Therapy Approaches for Oncology Highlight Manufacturing and Commercialization Strategies at Cell | Filippo Petti, CEO, Celyad Oncology SA.
00:10:00
AI Integration and SPAC Merger: Cellularity CEO Discusses Advances in Cancer Treatment and Lessons from the Pandemic| Robert Hariri, M.D., Ph.D., CEO, Celularity Inc.
00:10:00
Innovative Pharmaceuticals: Progress and Prospects Revealed by Industry Leader| Dr Maciej Wieczorek, CEO,Celon Pharma SA.
00:10:00
Biotech Innovator Advocates for Collaborative Healthcare Approach | André Choulika, CEO,Cellectis SA.
00:10:00
Exploring Cellectar's Cutting-Edge Cancer Treatment and Biotech Challenges | James V Caruso, CEO,Cellectar Biosciences Inc.
00:10:00
Unlocking UK's Cannabis Potential: Celadon Pharmaceuticals' Path| James Short , CEO,Celadon Pharmaceuticals PLC.
00:10:00
Harnessing the Power of the Placenta: A Journey in Cellular Medicine Innovation and Preservation of Human Performance| Robert Hariri, M.D., Ph.D., CEO, Celularity Inc.
00:10:00
Advancing Alzheimer's Treatment: CEO Discusses Promising Phase 2 Data and Multi-dimensional Drug Approach | Remi Barbier, CEO, Cassava Sciences Inc.
00:10:00
Carmat's clinical developments, production capabilities, and financial situation | Stéphane Piat, CEO, Carmat SA.
00:10:00
Alzheimer's Disease Solutions | Remi Barbier, CEO, Cassava Sciences Inc.
00:10:00
Unique Cell Therapy Platform's Promise| Steven Kelly, CEO,Carisma Therapeutics Inc.
00:10:00
A pioneering figure in CRISPR technology, recognized for her outstanding contributions to science and healthcare, shaping the future of biotechnology | Rachel Haurwitz, CEO, Caribou Biosciences Inc.
00:10:00
Analyzing the Biotechnology Market: Insights into Trends, Challenges, and Future Outlook | André Choulika, CEO,Cellectis SA.
00:10:00
Insights into French Biotech: Challenges and Opportunities in Healthcare Innovation Explored by Industry Expert | André Choulika, CEO,Cellectis SA.
00:10:00
Advancing Cardiac Solutions: A Conversation on Carmat's Breakthroughs and Future Goals | Stéphane Piat, CEO, Carmat SA.
00:10:00
Advancements in Biocompatible Artificial Heart Technology and Future Prospects | Stéphane Piat, CEO, Carmat SA.

© 2017 - Townhall + Tv